InvestorsHub Logo
Followers 371
Posts 5975
Boards Moderated 0
Alias Born 05/19/2011

Re: None

Friday, 02/01/2013 12:11:15 PM

Friday, February 01, 2013 12:11:15 PM

Post# of 130517
Any retesting will be redone in academica, and not by the Company. Many new discoveries and uses could come from MANF at this academica stage.

Gerald
_______________________________
I asked Gerald if there was any retesting pending at this time.

Hello Jeff,
I stated in my last Chairman's Blog post that we were moving forward with IND-enabling and human clinical studies (This is huge news) , and that further testing would be done in academia to determine optimal rodent model dosing regimens, which have nothing to do with human dosing regimens.

Why would the Company need to do a retest, and where did this notion come from? It certainly did not come from me. The results are the results. We believe them as they are and there is clear efficacy.

Gerald
http://www.thechairmansblog.com/author/gerald-commissiong